These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36293443)

  • 1. Synthesis, Anticancer and Antitubercular Properties of New Chalcones and Their Nitrogen-Containing Five-Membered Heterocyclic Hybrids Bearing Sulfonamide Moiety.
    Castaño LF; Quiroga J; Abonia R; Insuasty D; Vidal OM; Seña R; Rubio V; Puerto G; Nogueras M; Cobo J; Guzman J; Insuasty A; Insuasty B
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity.
    Castaño LF; Cuartas V; Bernal A; Insuasty A; Guzman J; Vidal O; Rubio V; Puerto G; Lukáč P; Vimberg V; Balíková-Novtoná G; Vannucci L; Janata J; Quiroga J; Abonia R; Nogueras M; Cobo J; Insuasty B
    Eur J Med Chem; 2019 Aug; 176():50-60. PubMed ID: 31096118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives.
    Ngameni B; Cedric K; Mbaveng AT; Erdoğan M; Simo I; Kuete V; Daştan A
    Bioorg Med Chem Lett; 2021 Mar; 35():127827. PubMed ID: 33508467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering the Potential of Chalcone-Sulfonamide Hybrids: A Systematic Review on Their Anticancer Activity and Mechanisms of Action.
    Souza JMT; Silva SANM; Rocha RBD; Machado FDS; Marinho Filho JDB; Araújo AJ
    Cell Biochem Funct; 2024 Sep; 42(7):e70001. PubMed ID: 39425507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.
    de Oliveira NS; de Souza LG; de Almeida VM; Barreto ARR; Carvalho-Gondim F; Schaeffer E; Santos-Filho OA; Rossi-Bergmann B; da Silva AJM
    Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300440. PubMed ID: 38048546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazole-Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation.
    Kasetti AB; Singhvi I; Nagasuri R; Bhandare RR; Shaik AB
    Molecules; 2021 May; 26(10):. PubMed ID: 34064806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcuminoid Chalcones: Synthesis and Biological Activity against the Human Colon Carcinoma (Caco-2) Cell Line.
    Olender D; Sowa-Kasprzak K; Pawełczyk A; Skóra B; Zaprutko L; Szychowski KA
    Curr Med Chem; 2024; 31(33):5397-5416. PubMed ID: 37779412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient access to domain-integrated estradiol-flavone hybrids via the corresponding chalcones and their in vitro anticancer potential.
    Molnár B; Gopisetty MK; Nagy FI; Adamecz DI; Kása Z; Kiricsi M; Frank É
    Steroids; 2022 Nov; 187():109099. PubMed ID: 35970223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazopyridine chalcones as potent anticancer agents: Synthesis, single-crystal X-ray, docking, DFT and SAR studies.
    Soumyashree DK; Reddy DS; Nagarajaiah H; Naik L; Savanur HM; Shilpa CD; Sunitha Kumari M; Shanavaz H; Padmashali B
    Arch Pharm (Weinheim); 2023 Jul; 356(7):e2300106. PubMed ID: 37208792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
    Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
    Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Antiproliferative Activity of Novel Dehydroabietic Acid-Chalcone Hybrids.
    Grigoropoulou S; Manou D; Antoniou AI; Tsirogianni A; Siciliano C; Theocharis AD; Athanassopoulos CM
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational and Molecular Docking Studies of New Benzene Sulfonamide Drugs with Anticancer and Antioxidant Effects.
    Mohamed HS; Abdelgawad MA; Hegab M; Hamza ZS; Nagdy AM; Ahmed SA; Ahmed OM; Ghoneim MM
    Curr Org Synth; 2023; 20(3):339-350. PubMed ID: 36214306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
    Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
    Gibson MZ; Nguyen MA; Zingales SK
    Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer Activity of Natural and Synthetic Chalcones.
    Constantinescu T; Lungu CN
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Bioactivity of Reduced Chalcones Containing Sulfonamide Side Chains.
    Noreljaleel AEM; Wilhelm A; Bonnet SL; van der Westhuizen JH
    J Nat Prod; 2018 Jan; 81(1):41-48. PubMed ID: 29309141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
    Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
    Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
    Ramírez-Prada J; Robledo SM; Vélez ID; Crespo MDP; Quiroga J; Abonia R; Montoya A; Svetaz L; Zacchino S; Insuasty B
    Eur J Med Chem; 2017 May; 131():237-254. PubMed ID: 28329730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer activity of novel 3-(furan-2-yl)pyrazolyl and 3-(thiophen-2-yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies.
    Helmy MT; Sroor FM; Mahrous KF; Mahmoud K; Hassaneen HM; Saleh FM; Abdelhamid IA; Mohamed Teleb MA
    Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100381. PubMed ID: 34939695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.